Accuray (ARAY) Net Equity Issued and Repurchased (2010 - 2025)
Accuray's (ARAY) quarterly Net Equity Issued and Repurchased came in at $856000.0 in Q1 2025, down 37.06% year-on-year from $1.4 million in Q1 2024, and down 37.06% quarter-over-quarter from $1.4 million in Q1 2024.
Accuray (ARAY) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
Accuray's Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $856000.0 for Q1 2025.
- On a quarterly basis, Net Equity Issued and Repurchased fell 37.06% year-over-year to $856000.0 in Q1 2025; TTM through Mar 2026 was $3.4 million, a 15.79% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 27.59% from the prior year.
- Net Equity Issued and Repurchased declined to $856000.0 in Q1 2025 per ARAY's latest filing, from $1.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $1.4 million in Q1 2024 and bottomed at $856000.0 in Q1 2025.
- The 3-year median for Net Equity Issued and Repurchased is $1.1 million (2023), against an average of $1.1 million.
- Across the five-year window, Net Equity Issued and Repurchased advanced 19.4% in 2024 and slumped 37.06% in 2025, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $1.1 million in 2023, then gained by 19.4% to $1.4 million in 2024, then slumped by 37.06% to $856000.0 in 2025.
- Per Business Quant, the three latest ARAY Net Equity Issued and Repurchased figures stand at $856000.0 (Q1 2025), $1.4 million (Q1 2024), and $1.1 million (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 856,000.00 |
| Mar 31, 2025 | 856,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Sep 30, 2013 | 629,000.00 |
| Sep 30, 2013 | 629,000.00 |
| Jun 30, 2013 | 1.90 Mn |
| Jun 30, 2013 | 1.90 Mn |
| Mar 31, 2013 | 408,000.00 |
| Mar 31, 2013 | 408,000.00 |
| Dec 31, 2012 | 4.90 Mn |
| Dec 31, 2012 | 4.90 Mn |
| Sep 30, 2012 | 251,000.00 |
| Sep 30, 2012 | 251,000.00 |
| Jun 30, 2012 | 1.75 Mn |
| Jun 30, 2012 | 1.75 Mn |
| Mar 31, 2012 | 674,000.00 |
| Mar 31, 2012 | 674,000.00 |